EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Gut Microbiota Alterations and Circulating Imidazole Propionate Levels Are Associated With Obstructive Coronary Artery Disease in People With HIV

Marius Trøseid iD, Antonio Molinaro, Marco Gelpi iD, Beate Vestad, Klaus Fuglsang Kofoed, Andreas Fuchs, Lars Køber iD, Kristian Holm, Thomas Benfield iD, Per M Ueland, Johannes R Hov, Susanne Dam Nielsen und 1 weitere

The Journal of Infectious Diseases · 2024

DOI: 10.1093/infdis/jiad604 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2024. Verfasst von Marius Trøseid und 12 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway. Hauptthemen laut MEDLINE: HIV Infections, Coronary Artery Disease, Gastrointestinal Microbiome, Imidazoles. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Rigshospitalet, Lundbeck Foundation, Novo Nordisk Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The impact of gut microbiota and its metabolites on coronary artery disease (CAD) in people with human immunodeficiency virus (PWH) is unknown. Emerging evidence suggests that imidazole propionate (ImP), a microbial metabolite, is linked with cardiometabolic diseases.

Methods

Fecal samples from participants of the Copenhagen Comorbidity in HIV infection (COCOMO) study were processed for 16S rRNA sequencing and ImP measured with liquid chromatography-tandem mass spectrometry. CAD severity was investigated by coronary computed tomography-angiography, and participants grouped according to obstructive CAD (n = 60), nonobstructive CAD (n = 80), or no CAD (n = 114).

Results

Participants with obstructive CAD had a gut microbiota with lower diversity and distinct compositional shift, with increased abundance of Rumiococcus gnavus and Veillonella, known producers of ImP. ImP plasma levels were associated with this dysbiosis, and significantly elevated in participants with obstructive CAD. However, gut dysbiosis but not plasma ImP was independently associated with obstructive CAD after adjustment for traditional and HIV-related risk factors (adjusted odds ratio, 2.7; 95% confidence interval, 1.1–7.2; P = .048).

Conclusions

PWH with obstructive CAD displays a distinct gut microbiota profile and increased circulating ImP plasma levels. Future studies should determine whether gut dysbiosis and related metabolites such as ImP are predictive of incident cardiovascular events.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsCoronary Artery DiseaseGastrointestinal MicrobiomeImidazolesHumansHIVDysbiosisRNA, Ribosomal, 16S

Stichwörter der Autor:innen

HIVcardiovascularcoronary artery diseasegut microbiotaimidazole propionate

Substanzen

5-imidazolepropionic acidRNA, Ribosomal, 16SImidazoles

Autor:innen und Institutionen

  • Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet, Oslo, Norway.
  • Section for Clinical Immunology and Infectious Diseases, Oslo University Hospital Rikshospitalet, Oslo, Norway.
  • Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Norwegian PSC Research Center, Department of Transplantation Medicine, Oslo University Hospital, Oslo, Norway.
  • Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Department of Cardiology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

ORCID-Profile: Marius Trøseid, Marco Gelpi, Lars Køber, Thomas Benfield

Förderung

  • Rigshospitalet
  • Lundbeck Foundation
  • Novo Nordisk Foundation
  • South-Eastern Norway Regional Health Authority
  • Research Council of Norway

Zitieren

APA

Trøseid, M., Molinaro, A., Gelpi, M., Vestad, B., Kofoed, K. F., Fuchs, A., Køber, L., Holm, K., Benfield, T., Ueland, P. M., Hov, J. R., Nielsen, S. D., & Knudsen, A. D. (2024). Gut Microbiota Alterations and Circulating Imidazole Propionate Levels Are Associated With Obstructive Coronary Artery Disease in People With HIV. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiad604

Vancouver

Trøseid M, Molinaro A, Gelpi M, Vestad B, Kofoed KF, Fuchs A, et al. Gut Microbiota Alterations and Circulating Imidazole Propionate Levels Are Associated With Obstructive Coronary Artery Disease in People With HIV. The Journal of Infectious Diseases. 2024. doi:10.1093/infdis/jiad604

BibTeX
@article{Trseid2024,
  author = {Trøseid, Marius and Molinaro, Antonio and Gelpi, Marco and Vestad, Beate and Kofoed, Klaus Fuglsang and Fuchs, Andreas and Køber, Lars and Holm, Kristian and Benfield, Thomas and Ueland, Per M and Hov, Johannes R and Nielsen, Susanne Dam and Knudsen, Andreas Dehlbæk},
  title = {Gut Microbiota Alterations and Circulating Imidazole Propionate Levels Are Associated With Obstructive Coronary Artery Disease in People With HIV},
  journal = {The Journal of Infectious Diseases},
  year = {2024},
  doi = {10.1093/infdis/jiad604}
}
Kostenlos starten →